Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients

Table 4 Effect modification by a very high level of uric acid (> 475 μmol/L) of the associations in the main model

Variable	Not having elevated levels of UA			Having elevated levels of UA
	OR	95%CI	P value	OR	95%CI	P value
Age (years)	1.05	1.01–1.08	0.01	1.08	1.04–1.12	< 0.01
Receiving hyperuricemia treatment	1.76	0.66–4.69	0.26	2.09	0.86–5.08	0.10
Having previous cardiovascular events	63.07	16.14–246.40	< 0.01	72.82	9.09–583.34	< 0.01
Having left ventricular hypertrophy	10.97	1.28–94.06	< 0.01	6.48	0.74–56.58	0.09
Having anemia	6.08	2.32–15.92	< 0.01	6.46	2.46–16.95	< 0.01

OR: Odds ratio; UA: Uric acid.